SLC7A11 and prostate carcinoma: This study highlights the role of the SNHG3/miR-152-3p/SLC7A11 axis in promoting prostate cancer progression by influencing methionine-dependence, underscoring the significance of miR-152-3p in inhibiting prostate cancer (81).